Although this approach is a better strategy to overcome the low sensitivity of EpCAM-based systems, capturing CTCs with a single marker is almost ineffective due to the heterogeneous nature of HCC; therefore, a combination of markers is needed. The gene discussed is EPCAM; the disease is hepatocellular carcinoma.